-
Trevi Therapeutics (NASDAQ:TRVI) Earns Buy Rating from D. Boral Capital
Source: Buzz FX / 20 Mar 2025 07:16:17 America/Chicago
Trevi Therapeutics (NASDAQ:TRVI) Earns Buy Rating from D. Boral Capital Written by MarketBeat March 20, 2025 Share Link copied to clipboard. Remove Ads Trevi Therapeutics ( NASDAQ:TRVI - Get Free Report ) 's stock had its "buy" rating reite
Read more...